|
ZBTB43 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.661000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.442400E-01 |
| Normal-vs-Stage2 |
1.962560E-01 |
| Normal-vs-Stage3 |
5.720000E-01 |
| Normal-vs-Stage4 |
5.691200E-01 |
| Stage1-vs-Stage2 |
2.609000E-01 |
| Stage1-vs-Stage3 |
3.505400E-01 |
| Stage1-vs-Stage4 |
5.387600E-01 |
| Stage2-vs-Stage3 |
1.254170E-01 |
| Stage2-vs-Stage4 |
2.313600E-01 |
| Stage3-vs-Stage4 |
9.895400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.538800E-01 |
| Normal-vs-AfricanAmerican |
1.256190E-01 |
| Normal-vs-Asian |
1.137620E-01 |
| Caucasian-vs-AfricanAmerican |
1.470770E-01 |
| Caucasian-vs-Asian |
2.752000E-01 |
| AfricanAmerican-vs-Asian |
1.734560E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.993400E-01 |
| Normal-vs-Female |
2.867200E-01 |
| Male-vs-Female |
4.901800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.962200E-01 |
| Normal-vs-Extreme_Weight |
8.749400E-01 |
| Normal-vs-Obese |
1.666360E-01 |
| Normal-vs-Extreme_Obese |
3.705000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.007600E-01 |
| Normal_Weight-vs-Obese |
2.424400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.516000E-01 |
| Extreme_Weight-vs-Obese |
1.354790E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.880000E-01 |
| Obese-vs-Extreme_Obese |
9.067200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.620000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.122200E-02 |
| Normal-vs-Age(61-80Yrs) |
9.373800E-01 |
| Normal-vs-Age(81-100Yrs) |
8.210400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.140200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.478600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.867800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.228100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.376400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.473000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.612180E-02 |
| Normal-VS-Type2 PRCC |
1.355820E-02 |
| Normal-VS-KIRP CIMP |
5.910200E-01 |
| Normal-VS-Unclassified PRCC |
7.542200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.54629999973943E-07 |
| Type1 PRCC-VS-KIRP CIMP |
5.552200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.776770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.885800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.248200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.448200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.204400E-01 |
| Normal-vs-N1 |
9.220800E-01 |
| Normal-vs-N2 |
2.590400E-01 |
| N0-vs-N1 |
4.448000E-01 |
| N0-vs-N2 |
6.830600E-01 |
| N1-vs-N2 |
5.239200E-01 |
|
|
